Versa Vascular appoints Bill Shields as CEO and announces $15 million in expanded Series C funding.
Amount Raised
$15 Million
Round Type
Series C
Santa CruzBiotechnologyHealth CareMedicalMedical DeviceInvestors
Description
Versa Vascular has expanded its Series C funding by securing an additional $15 million. The company continues to grow under the leadership of newly appointed CEO Bill Shields. This funding will help propel its ongoing initiatives. Investors are showing increased confidence in the company's vision and strategy.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Versa Vascular that raised within 45 days of this round, from Fundz verified event records.
- Redefine Surgery raised $10M (Pre-Seed) on September 24, 2026.
- SenseTime MedTech raised $100M (Series B) on September 24, 2026.
- UltraSight raised $24M (Series B) on September 23, 2026.
- Anaconda BioMed raised $56M on September 23, 2026.
- Cascader raised an undisclosed amount (Seed) on September 23, 2026.
- Aqua Medical raised an undisclosed amount (Series B) on September 23, 2026.
Who to call at Versa Vascular, and when
A new round usually means Versa Vascular is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Versa Vascular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Versa Vascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Versa Vascular. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Versa Vascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Versa Vascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.